# Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)

> **NCT01218360** · — · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 71 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** Physician standard-of-care

## Key facts

- **NCT ID:** NCT01218360
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2015-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01218360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01218360, "Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)". Retrieved via MORVS 2026-10-09 from https://api.morvs.ai/clinical/NCT01218360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*